Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction

Author： Raymond G. Schlienger   Lorenz M. Fischer  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.27, Iss.14, 2004-01, pp. : 1157-1165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation: Can They Prevent Acute Myocardial Infarction?

By Schlienger R.G.   Meier C.R.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 3, 2003-01 ,pp. : 149-162

Adis International

Access to resources Recommend Favorite

Selective serotonin re-uptake inhibitors and the risk of bleeding

By Weinrieb Robert M   Auriacombe Marc   Lynch Kevin G   Lewis James D  

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 337-344

Informa Healthcare

Access to resources Recommend Favorite

Overdose Risk with Selective Serotonin Reuptake Inhibitors

By Muldoon C.  

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1205-1206

Adis International

Access to resources Recommend Favorite

Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents

By Ian C.K. Wong  

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite

Polymorphism of the Serotonin Transporter: Implications for the Use of Selective Serotonin Reuptake Inhibitors

By Lotrich F.E.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 3, 2001-01 ,pp. : 153-164

Adis International

Access to resources Recommend Favorite